Research study
Program year 2024
Source: CMS Open Payments
Rise
Research payments
$1,225,677
Through program year 2024, $1,225,677 in research payments was reported against Rise, across 11 payments.
- Paid by (largest first)
- Davol Inc.; C. R. Bard, Inc. & Subsidiaries; Genentech, Inc. and 1 more
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $235,934 | 1 |
| 2022 | Research | $814,159 | 4 |
| 2021 | Research | $130,640 | 1 |
| 2020 | Research | $21,900 | 1 |
| 2019 | Research | $23,044 | 4 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
4 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.